STOCK TITAN

VitalHub Announces Inclusion in the TSX30

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

VitalHub (TSX: VHI, OTCQX: VHIBF) has been recognized in the prestigious TSX30 list for 2025, ranking 18th among the top 30 performing stocks on the Toronto Stock Exchange. The company achieved remarkable growth with a 310% dividend-adjusted share price appreciation and a 429% increase in market capitalization over the past three years.

CEO Dan Matlow attributed this achievement to the team's dedication and stakeholder trust, while reaffirming the company's commitment to advancing healthcare digitization globally. The TSX30, established in 2019, is an annual ranking that showcases the top-performing TSX-listed companies based on three-year dividend-adjusted share price performance.

VitalHub (TSX: VHI, OTCQX: VHIBF) è stata inserita nella prestigiosa TSX30 per il 2025, piazzandosi 18ª tra le 30 azioni migliori per performance sulla Borsa di Toronto. Negli ultimi tre anni la società ha registrato una crescita notevole, con un aumento del prezzo delle azioni rettificato per i dividendi del 310% e un incremento della capitalizzazione di mercato del 429%.

Il CEO Dan Matlow ha attribuito questo risultato all’impegno del team e alla fiducia degli stakeholder, confermando al contempo l’impegno dell’azienda a promuovere la digitalizzazione della sanità a livello globale. La TSX30, istituita nel 2019, è una classifica annuale che mette in evidenza le società quotate al TSX con le migliori performance triennali del prezzo delle azioni rettificato per i dividendi.

VitalHub (TSX: VHI, OTCQX: VHIBF) ha sido reconocida en la prestigiosa lista TSX30 para 2025, ocupando el puesto 18 entre las 30 acciones con mejor rendimiento en la Bolsa de Toronto. En los últimos tres años la compañía registró un crecimiento notable, con una apreciación del precio de las acciones ajustada por dividendos del 310% y un aumento del 429% en la capitalización de mercado.

El CEO Dan Matlow atribuyó este logro a la dedicación del equipo y a la confianza de los stakeholders, reafirmando además el compromiso de la empresa con la digitalización de la atención sanitaria a nivel global. La TSX30, creada en 2019, es un ranking anual que muestra las compañías cotizadas en el TSX con mejor rendimiento de precio de acción ajustado por dividendos a tres años.

VitalHub (TSX: VHI, OTCQX: VHIBF)가 권위 있는 2025년 TSX30에 선정되어 토론토 증권거래소 상위 30개 우수 종목 중 18위를 차지했습니다. 지난 3년간 회사는 배당금 조정 주가 310% 상승시가총액 429% 증가라는 눈에 띄는 성과를 냈습니다.

CEO 댄 매틀로우(Dan Matlow)는 이 성과를 팀의 헌신과 이해관계자들의 신뢰 덕분으로 돌리며, 전 세계적으로 의료 디지털화 추진에 대한 회사의 의지를 재확인했습니다. 2019년에 도입된 TSX30은 3년간 배당금 조정 주가 성과를 기준으로 TSX 상장 기업 중 우수 기업을 매년 선별해 발표하는 순위입니다.

VitalHub (TSX: VHI, OTCQX: VHIBF) a été reconnue dans la prestigieuse liste TSX30 pour 2025, se classant 18e parmi les 30 meilleures actions de la Bourse de Toronto. Au cours des trois dernières années, la société a connu une croissance remarquable, avec une appréciation du cours ajustée des dividendes de 310% et une hausse de 429% de la capitalisation boursière.

Le PDG Dan Matlow a attribué cette réussite à la détermination de l’équipe et à la confiance des parties prenantes, tout en réaffirmant l’engagement de l’entreprise à promouvoir la numérisation des soins de santé à l’échelle mondiale. La TSX30, créée en 2019, est un classement annuel qui met en lumière les sociétés cotées au TSX affichant les meilleures performances du cours sur trois ans ajustées des dividendes.

VitalHub (TSX: VHI, OTCQX: VHIBF) wurde in die renommierte TSX30-Liste für 2025 aufgenommen und belegte Platz 18 unter den 30 besten Aktien an der Toronto Stock Exchange. Das Unternehmen erzielte in den vergangenen drei Jahren bemerkenswertes Wachstum mit einer aktienkursbereinigten Steigerung um 310% (inkl. Dividenden) und einem Marktkapitalisierungszuwachs von 429%.

CEO Dan Matlow schrieb diesen Erfolg dem Engagement des Teams und dem Vertrauen der Stakeholder zu und bekräftigte zugleich das Bekenntnis des Unternehmens zur weltweiten Digitalisierung des Gesundheitswesens. Die TSX30, die 2019 eingeführt wurde, ist ein jährliches Ranking, das die TSX-notierten Unternehmen mit der besten dreijährigen, dividendenbereinigten Aktienkursentwicklung ausweist.

Positive
  • Achieved 310% dividend-adjusted share price appreciation over three years
  • Market capitalization increased by 429% over three years
  • Ranked 18th in the prestigious TSX30 list
Negative
  • None.

Toronto, Ontario--(Newsfile Corp. - September 9, 2025) -  Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") announced today that it has been included in the TSX30 for 2025. The Company ranked 18 on the list of top 30 performing stocks on Toronto Stock Exchange, with a dividend-adjusted share price appreciation of 310% over the course of the last three years, which correlates to a 429% increase in market capitalization over the same time period.

"We are pleased to be recognized again this year as one of the top performers on the TSX," said Dan Matlow, CEO of VitalHub. "This recognition is a testament to our team's hard work and the trust our customers and investors place in us. We remain committed to our ambitious growth objectives advancing the progress of healthcare digitization globally."

The TSX30 List, established in 2019, is an annual ranking that identifies the top 30 stocks based on their dividend-adjusted share price performance over a three-year period. It celebrates the achievements of the listed companies and underscores the robustness and growth potential of Canada's dynamic public markets. VitalHub is honoured to be named one of the 30 TSX issuers included in this year's TSX30.

About VitalHub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,000 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 500 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka. For more information about VitalHub (TSX: VHI) (OTCQX: VHIBF), please visit www.vitalhub.com and LinkedIn.

Contact Information

Christian Sgro, CPA, CA, CFA
Head of IR and M&A Specialist
(365) 363-6433
christian.sgro@vitalhub.com

Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
dan.matlow@vitalhub.com

Cautionary Statement

Certain statements contained in this news release may constitute "forward-looking information" or "financial outlook" within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265534

FAQ

What is VitalHub's ranking in the TSX30 2025 list?

VitalHub ranked 18th on the TSX30 2025 list of top-performing stocks on the Toronto Stock Exchange.

How much has VitalHub's (VHIBF) stock price appreciated over the past three years?

VitalHub's dividend-adjusted share price appreciated by 310% over the past three years.

What was the increase in VitalHub's market capitalization from 2022 to 2025?

VitalHub's market capitalization increased by 429% over the three-year period.

What is the TSX30 list?

The TSX30 is an annual ranking established in 2019 that identifies the top 30 performing stocks on the Toronto Stock Exchange based on dividend-adjusted share price performance over a three-year period.

Who is the CEO of VitalHub (VHIBF)?

Dan Matlow is the CEO of VitalHub.
Vitalhub

OTC:VHIBF

VHIBF Rankings

VHIBF Latest News

VHIBF Stock Data

508.29M
34.32M
15.06%
28.48%
Health Information Services
Healthcare
Link
Canada
Toronto